United States
20
2014-11-13
The entities that hold a legal rights for patent applications filed by inventor AbbVie Inc.:
AbbVie Inc. from , US has applied for patents for these inventions. The list has both pending applications and granted patents:
NAMPT inhibitors
#2 | 2014-10-02Anti-infective agents and uses thereof
#3 | 2014-08-14Syringe with two-stage sealing pressure
#4 | 2014-06-12CELL CULTURE METHODS TO REDUCE ACIDIC SPECIES
#5 | 2014-03-13Purification of antibodies using hydrophobic interaction chromatography
#6 | 2013-12-26LOW FLUSH NIACIN FORMULATION
#7 | 2013-12-26FORMULATIONS OF NONOPIOID AND CONFINED OPIOID ANALGESICS
#8 | 2013-12-26Cell culture methods to reduce acidic species
#9 | 2013-12-26RADIOLABELED 5-HT6 LIGANDS
#10 | 2013-12-26Radiolabeled PDE10A ligands
#11 | 2013-12-19Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
#12 | 2013-12-12Composition and method for the diagnosis and treatment of iron-related disorders
#13 | 2013-12-12COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITE DEGENERATION
#14 | 2013-12-12Composition and method for the diagnosis and treatment of iron-related disorders
#15 | 2013-11-214-(4-pyridinyl)-benzamides and their use as rock activity modulators
#16 | 2013-11-07BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
#17 | 2013-08-29Pyridopyrimidinone inhibitors of kinases
#18 | 2013-08-22Method for preventing or reducing acute renal failure by administration of therapeutically active α-MSH analogues
#19 | 2013-08-15Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
#20 | 2013-08-15(4-chloro-2-fluoro-N-(2-fluorophenyl)-5-[(8aR)-hexahydropyrrolo-[1,2-a]pyrazin-2(1H)-ylcarbonyl]-benzenesulfonamide, and pharmaceutically acceptable salts thereof
391225 ⎘